NeuroRisk.ai
ENTERPRISE SOLUTION

Business Development & Licensing Intelligence

Screen organizations, therapeutic areas and markets for partnership and licensing research.

Request tailored demo →Explore free intelligence

What you can evaluate

Companies and sponsors, disease areas, recruiting trials, countries, institutions, research signals and market opportunity.

Enterprise workflow

Comparative briefs, API access, exports, evidence-linked analysis and recurring monitoring.

Start with evidence

Explore the public intelligence layer first. Enterprise access is designed for deeper comparative and organizational workflows.